Zhang H, Lin C, Chen Y, Shen X, Wang R, Chen Y
J Cell Mol Med. 2025; 29(1):e70351.
PMID: 39804102
PMC: 11726689.
DOI: 10.1111/jcmm.70351.
Ashcroft F, Bourboula A, Mahammad N, Barbayianni E, Feuerherm A, Nguyen T
Nat Commun. 2025; 16(1):164.
PMID: 39747052
PMC: 11696576.
DOI: 10.1038/s41467-024-55536-9.
Cai Z, Poulos R, Aref A, Robinson P, Reddel R, Zhong Q
Cancer Res Commun. 2024; 4(12):3151-3164.
PMID: 39530738
PMC: 11652962.
DOI: 10.1158/2767-9764.CRC-24-0285.
Choi J, Lee J, Kang U, Chang H, Cho K
Alzheimers Res Ther. 2024; 16(1):229.
PMID: 39415193
PMC: 11481771.
DOI: 10.1186/s13195-024-01583-9.
Dong X, Zhang D, Zhang X, Liu Y, Liu Y
NPJ Syst Biol Appl. 2024; 10(1):114.
PMID: 39362887
PMC: 11449910.
DOI: 10.1038/s41540-024-00445-2.
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.
Valerio M, Inno A, Zambelli A, Cortesi L, Lorusso D, Viassolo V
Cancers (Basel). 2024; 16(16).
PMID: 39199616
PMC: 11352240.
DOI: 10.3390/cancers16162845.
The Ihara zeta function as a partition function for network structure characterisation.
Wang J, Hancock E
Sci Rep. 2024; 14(1):18386.
PMID: 39117698
PMC: 11310400.
DOI: 10.1038/s41598-024-68882-x.
CGMega: explainable graph neural network framework with attention mechanisms for cancer gene module dissection.
Li H, Han Z, Sun Y, Wang F, Hu P, Gao Y
Nat Commun. 2024; 15(1):5997.
PMID: 39013885
PMC: 11252405.
DOI: 10.1038/s41467-024-50426-6.
A gray box framework that optimizes a white box logical model using a black box optimizer for simulating cellular responses to perturbations.
Kim Y, Han Y, Hopper C, Lee J, Joo J, Gong J
Cell Rep Methods. 2024; 4(5):100773.
PMID: 38744288
PMC: 11133856.
DOI: 10.1016/j.crmeth.2024.100773.
Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.
Wang M, Yan X, Dong Y, Li X, Gao B
PLoS Comput Biol. 2024; 20(5):e1012113.
PMID: 38728362
PMC: 11230636.
DOI: 10.1371/journal.pcbi.1012113.
Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in triple negative breast cancer.
Agrawal P, Jain N, Gopalan V, Timon A, Singh A, Rajagopal P
iScience. 2024; 27(5):109752.
PMID: 38699227
PMC: 11063905.
DOI: 10.1016/j.isci.2024.109752.
Proteomics appending a complementary dimension to precision oncotherapy.
Zhou Z, Zhang R, Zhou A, Lv J, Chen S, Zou H
Comput Struct Biotechnol J. 2024; 23:1725-1739.
PMID: 38689716
PMC: 11058087.
DOI: 10.1016/j.csbj.2024.04.044.
A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
Zhang N, Ma F, Guo D, Pang Y, Wang C, Zhang Y
PLoS Comput Biol. 2024; 20(4):e1012068.
PMID: 38683860
PMC: 11081510.
DOI: 10.1371/journal.pcbi.1012068.
StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling.
Giudice L, Mohamed A, Malm T
PLoS Comput Biol. 2024; 20(4):e1012022.
PMID: 38607982
PMC: 11042724.
DOI: 10.1371/journal.pcbi.1012022.
Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome.
Desai S, Ahmad S, Bawaskar B, Rashmi S, Mishra R, Lakhwani D
NAR Cancer. 2024; 6(1):zcae010.
PMID: 38487301
PMC: 10939354.
DOI: 10.1093/narcan/zcae010.
Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide.
Carter T, Valenzuela R, Yerukala Sathipati S, Medina-Flores R
Front Genet. 2024; 14:1320789.
PMID: 38259614
PMC: 10802164.
DOI: 10.3389/fgene.2023.1320789.
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer.
Geng H, Qian R, Zhong Y, Tang X, Zhang X, Zhang L
Cancer Gene Ther. 2023; 31(2):334-348.
PMID: 38040871
DOI: 10.1038/s41417-023-00706-y.
Integrating somatic mutation profiles with structural deep clustering network for metabolic stratification in pancreatic cancer: a comprehensive analysis of prognostic and genomic landscapes.
Zou M, Li H, Su D, Xiong Y, Wei H, Wang S
Brief Bioinform. 2023; 25(1).
PMID: 38040491
PMC: 10783866.
DOI: 10.1093/bib/bbad430.
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells.
Chrisochoidou Y, Roy R, Farahmand P, Gonzalez G, Doig J, Krasny L
Cell Death Dis. 2023; 14(11):725.
PMID: 37938546
PMC: 10632403.
DOI: 10.1038/s41419-023-06240-x.
Desmosome mutations impact the tumor microenvironment to promote melanoma proliferation.
Baron M, Tagore M, Wall P, Zheng F, Barkley D, Yanai I
bioRxiv. 2023; .
PMID: 37786690
PMC: 10541613.
DOI: 10.1101/2023.09.19.558457.